August 9 – Walvax Biotechnology (RCode:300142) recorded a 48.24-percent year-on-year surge in net profits for the first half of 2011 to 83.85 million yuan, reports p5w.net, citing a company filing. Sale revenues during that period grew 42.64 percent year-on-year to 180 million yuan.